Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

Similar articles for PubMed (Select 18646355)

1.

Thyroid-stimulating hormone and follicle-stimulating hormone status in Hispanic women during the menopause transition.

Rojas LV, Nieves K, Suarez E, Ortiz AP, Rivera A, Romaguera J.

Ethn Dis. 2008 Spring;18(2 Suppl 2):S2-230-4.

PMID:
18646355
2.

Correlation analysis for follicle-stimulating hormone and C-terminal cross-linked telopetides of type i collagen in menopausal transition women with osteoporosis.

Wang B, Song Y, Chen Y, Wang ES, Zheng D, Qu F, Zhou JH.

Int J Clin Exp Med. 2015 Feb 15;8(2):2417-22. eCollection 2015.

3.

[Correlation between follicle-stimulating hormone and total procollagen I N-terminal propeptide in perimenopausal women].

Wang B, Chen Y, Song Y, Wang ES, Zheng D, Qu F, Zhou JH.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2015 Jan;44(1):85-9. Chinese.

PMID:
25851981
4.

Statins and thyroid-stimulating hormone.

Leese G.

Clin Endocrinol (Oxf). 2015 Feb 24. doi: 10.1111/cen.12757. [Epub ahead of print] No abstract available.

PMID:
25711238
5.

[Influence of Selected Reproductive Factors and Smoking on Age at Menopause.]

Rumianowski B, Rotter I, Brodowska A, Adler G, Kowalski J, Karakiewicz B, Laszczyńska M.

Gesundheitswesen. 2015 Jan 26. [Epub ahead of print] German.

PMID:
25622211
6.

Thyroid-stimulating hormone acutely increases levels of circulating pro-coagulant microparticles.

Burger D, Gagnon A, Lochnan HA, Mahzari M, Sorisky A.

Clin Endocrinol (Oxf). 2014 Dec 29. doi: 10.1111/cen.12709. [Epub ahead of print] No abstract available.

PMID:
25557124
7.

Weight loss increases follicle stimulating hormone in overweight postmenopausal women [corrected].

Kim C, Randolph JF, Golden SH, Labrie F, Kong S, Nan B, Barrett-Connor E.

Obesity (Silver Spring). 2015 Jan;23(1):228-33. doi: 10.1002/oby.20917. Epub 2014 Oct 8. Erratum in: Obesity (Silver Spring). 2015 Apr;23(4):915.

PMID:
25294746
8.

[The severity of menopausal symptoms and cardiovascular risk in women].

Isaeva AS, Vovchenko MN.

Georgian Med News. 2014 Jun;(231):21-6. Russian.

PMID:
25020165
9.

Effects of new sports tennis type exercise on aerobic capacity, follicle stimulating hormone and N-terminal telopeptide in the postmenopausal women.

Shin HJ, Lee HY, Cho HY, Park YJ, Moon HH, Lee SH, Lee SK, Kim MK.

J Exerc Rehabil. 2014 Apr 30;10(2):89-91. doi: 10.12965/jer.140097. eCollection 2014 Apr.

10.

Vaginal pH: A marker for menopause.

Panda S, Das A, Singh AS, Pala S.

J Midlife Health. 2014 Jan;5(1):34-7. doi: 10.4103/0976-7800.127789.

11.

Waiting for an elevated FSH--too late a marker of reduced ovarian reserve?

Kahapola Arachchige KM, Wardrop R, Lim EM, Stuckey B, Hadlow N.

Aust N Z J Obstet Gynaecol. 2012 Oct;52(5):460-4. doi: 10.1111/j.1479-828X.2012.01464.x. Epub 2012 Jul 16.

PMID:
22804862
12.

The impact of serum FSH and estradiol on postmenopausal osteoporosis related to time since menopause.

Yoldemir T, Erenus M, Durmusoglu F.

Gynecol Endocrinol. 2012 Nov;28(11):884-8. doi: 10.3109/09513590.2012.683066. Epub 2012 Jun 25.

PMID:
22731753
13.

Hormone profile of menopausal women in Havana.

Navarro D, Acosta A, Robles E, Díaz C.

MEDICC Rev. 2012 Apr;14(2):13-5.

14.

High normal thyroid-stimulating hormone is associated with arterial stiffness in healthy postmenopausal women.

Lambrinoudaki I, Armeni E, Rizos D, Georgiopoulos G, Kazani M, Alexandrou A, Deligeoroglou E, Livada A, Psychas C, Creatsa M, Bouboulis G, Alevizaki M, Stamatelopoulos K.

J Hypertens. 2012 Mar;30(3):592-9. doi: 10.1097/HJH.0b013e32834f5076.

PMID:
22227818
15.

Menopause as risk factor for oxidative stress.

Sánchez-Rodríguez MA, Zacarías-Flores M, Arronte-Rosales A, Correa-Muñoz E, Mendoza-Núñez VM.

Menopause. 2012 Mar;19(3):361-7. doi: 10.1097/gme.0b013e318229977d.

PMID:
21971210
16.

Age- and menopause-related differences in physiological factors of health quality in women aged 35-60.

Wiacek M, Jegal BS, Hagner W, Hagner-Derengowska M, Zubrzycki IZ.

Arch Gerontol Geriatr. 2012 Mar-Apr;54(2):385-90. doi: 10.1016/j.archger.2011.04.011. Epub 2011 May 17.

PMID:
21592597
17.

Relationship between serum estradiol and follicle-stimulating hormone levels and urodynamic results in women with stress urinary incontinence.

Ahn KH, Kim T, Hur JY, Kim SH, Lee KW, Kim YT.

Int Urogynecol J. 2011 Jun;22(6):731-7. doi: 10.1007/s00192-011-1359-6. Epub 2011 Jan 27.

PMID:
21271237
18.

FSH isoform pattern in classic galactosemia.

Gubbels CS, Thomas CM, Wodzig WK, Olthaar AJ, Jaeken J, Sweep FC, Rubio-Gozalbo ME.

J Inherit Metab Dis. 2011 Apr;34(2):387-90. doi: 10.1007/s10545-010-9180-9. Epub 2010 Sep 3.

19.

Correlations between gonadotropins level, vaginal cytology and menopause vessel-active phenomena.

Manea M, Popescu CF, Mitruţ P.

Rom J Morphol Embryol. 2009;50(4):631-7.

20.

Thyroid stimulating hormone is associated with metabolic syndrome in euthyroid postmenopausal women.

Park HT, Cho GJ, Ahn KH, Shin JH, Hong SC, Kim T, Hur JY, Kim YT, Lee KW, Kim SH.

Maturitas. 2009 Mar 20;62(3):301-5. doi: 10.1016/j.maturitas.2009.01.007. Epub 2009 Feb 27.

PMID:
19250778
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk